Elgethun Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-37,542
| Closed | -$2.22M | – | 154 |
|
|
2024
Q2 | $2.22M | Sell |
37,542
-475
| -1% | -$29.7K | 0.56% | 42 |
|
|
2024
Q1 | $3.02M | Sell |
38,017
-204
| -0.5% | -$15.6K | 0.76% | 36 |
|
|
2023
Q4 | $3.02M | Sell |
38,221
-340
| -0.9% | -$24.2K | 0.85% | 39 |
|
|
2023
Q3 | $2.66M | Buy |
38,561
+3,209
| +9% | +$227K | 0.8% | 37 |
|
|
2023
Q2 | $2.44M | Sell |
35,352
-771
| -2% | -$54.9K | 0.74% | 41 |
|
|
2023
Q1 | $2.75M | Sell |
36,123
-6,461
| -15% | -$542K | 0.87% | 39 |
|
|
2022
Q4 | $3.93M | Sell |
42,584
-204
| -0.5% | -$19.7K | 1.42% | 22 |
|
|
2022
Q3 | $4.08M | Sell |
42,788
-2,430
| -5% | -$241K | 1.63% | 17 |
|
|
2022
Q2 | $4.18M | Buy |
45,218
+38
| +0.1% | +$3.71K | 1.62% | 19 |
|
|
2022
Q1 | $4.57M | Buy |
45,180
+405
| +0.9% | +$42.5K | 1.55% | 20 |
|
|
2021
Q4 | $4.61M | Buy |
44,775
+354
| +0.8% | +$32.7K | 1.61% | 17 |
|
|
2021
Q3 | $3.77M | Buy |
44,421
+81
| +0.2% | +$6.79K | 1.3% | 24 |
|
|
2021
Q2 | $3.7M | Buy |
44,340
+27,783
| +168% | +$2.28M | 1.27% | 26 |
|
|
2021
Q1 | $1.25M | Buy |
16,557
+6,070
| +58% | +$442K | 0.48% | 44 |
|
|
2020
Q4 | $716K | Buy |
10,487
+5,727
| +120% | +$372K | 0.31% | 50 |
|
|
2020
Q3 | $282K | Sell |
4,760
-65
| -1% | -$4.04K | 0.15% | 67 |
|
|
2020
Q2 | $344K | Sell |
4,825
-217
| -4% | -$13.7K | 0.2% | 64 |
|
|
2020
Q1 | $299K | Sell |
5,042
-409
| -8% | -$27.3K | 0.17% | 68 |
|
|
2019
Q4 | $407K | Hold |
5,451
| – | – | 0.2% | 66 |
|
|
2019
Q3 | $341K | Buy |
5,451
+78
| +1% | +$4.62K | 0.18% | 67 |
|
|
2019
Q2 | $293K | Sell |
5,373
-1,029
| -16% | -$55.4K | 0.16% | 71 |
|
|
2019
Q1 | $345K | Sell |
6,402
-279
| -4% | -$17.2K | 0.2% | 71 |
|
|
2018
Q4 | $438K | Sell |
6,681
-608
| -8% | -$45.4K | 0.3% | 68 |
|
|
2018
Q3 | $582K | Hold |
7,289
| – | – | 0.38% | 59 |
|
|
2018
Q2 | $470K | Buy |
7,289
+375
| +5% | +$24.7K | 0.33% | 65 |
|
|
2018
Q1 | $430K | Sell |
6,914
-1,458
| -17% | -$105K | 0.3% | 76 |
|
|
2017
Q4 | $607K | Sell |
8,372
-1,752
| -17% | -$127K | 0.42% | 55 |
|
|
2017
Q3 | $823K | Sell |
10,124
-74
| -0.7% | -$5.85K | 0.6% | 43 |
|
|
2017
Q2 | $821K | Buy |
10,198
+4,693
| +85% | +$371K | 0.64% | 42 |
|
|
2017
Q1 | $432K | Buy |
5,505
+3,819
| +227% | +$305K | 0.35% | 56 |
|
|
2016
Q4 | $133K | Buy |
+1,686
| New | +$136K | 0.1% | 93 |
|
Other funds holding CVS
Elgethun Capital Management's CVS Position: Q3 2024 in Review
Elgethun Capital Management sold out of CVS Health (CVS) in Q3 2024, closing a stake of 37,542 shares — an estimated $2.22M sold.
Elgethun Capital Management first reported a position in CVS in Q4 2016 and held it in 31 quarters. The position peaked at $4.61M in Q4 2021. 1,841 funds tracked by Wall St. Rank hold CVS as of Q3 2024.
- Elgethun Capital Management reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
- Elgethun Capital Management sold 37,542 CVS Health shares in Q3 2024, an estimated $2.22M.
- Elgethun Capital Management first reported a position in CVS Health in Q4 2016 and held it in 31 quarters.
- Elgethun Capital Management's CVS Health position peaked at $4.61M in Q4 2021.
- 1,841 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.
Based on Elgethun Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.